Volumina is active in the field of tissue engineering and develops injectable 3D scaffolds for the reconstruction of volumes of soft tissues (fat, muscles, glandular tissues, supporting and connective tissues) that have been lost after tumor ablation, disease or trauma. Their solution can also be used for purely aesthetic purposes. The EPFL-spinoff aims to help patients regain durably, their physical and functional integrity. In addition to that, the startup enables plastic and reconstructive surgeons to safely and efficiently repair the body in 3D.
Volumina Medical’s first product offers an interesting solution for breast reconstruction after cancer treatment.
Breast cancer accounts for the highest healthcare costs in Europe, mainly due to the impact on breast cancer survivor’s quality of life and costly reconstruction procedures.
Surviving breast cancer however does not mean a woman gets her full life back. Breast cancer survivors are constantly reminded of their battle with cancer when they see themselves in the mirror. Reconstructive surgery is available but is currently costly, risky, highly invasive and results are temporary or don’t look natural.
Volumina Medical develops AdiPearl, an innovative injectable biomaterial. Purposefully designed, this biomaterial opens possibilities thought impossible so far.
The uniqueness of AdiPearlTM lies in its regeneration capacity. This key feature was obtained thanks to the interdisciplinary approach of the inventors, at the cross-section between physics, chemistry, and biology.
AdiPearl will improve the quality of life by bringing to breast cancer survivors a safe, effective, quality, and cost efficient breast reconstruction solution.
The company’s vision is to develop a range of solutions to help the body look and feel its best.